Fig. 3: Progression-free survival in the L-MIND Study (courtesy of Morphosys).
From: Diffuse large B-cell lymphoma: new targets and novel therapies
The median PFS is 16.2 months (95% CI: 6.3-NR).
Fig. 3: Progression-free survival in the L-MIND Study (courtesy of Morphosys). | Blood Cancer Journal
